February 21, 2011 (San Diego, California) — A low dose of the synthetic antifibronolytic agent tranexamic acid (TA) decreases the amount of blood loss and the need for blood transfusions during ...

Please provide your email address to receive an email when new articles are posted on . Compared with placebo, tranexamic acid was linked with reduced perioperative blood loss and transfusions for ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Tranexamic acid ...

Please provide your email address to receive an email when new articles are posted on . Tranexamic acid may be indicated for the prevention of heterotopic ossification. Patients undergoing surgery for ...

Safety of intraoperative tranexamic acid use on the risk of venous thromboembolism (VTE) in patients undergoing robotic assisted radical cystectomy (RARC). Univariable and multivariable cox-regression ...

For patients undergoing surgery for elbow trauma, treatment with the hemostatic drug tranexamic acid (TXA) is associated with a decreased incidence of heterotopic ossification (HO) – a common ...

A breakthrough could be coming in the way young people recover from surgery to reconstruct the anterior cruciate ligament (ACL) in the knee, a common sports injury. A new clinical trial soon will ...

Effect of type of antibiotics (Abx) on outcomes with immune checkpoint inhibitors (ICIs) in patients (pts) with metastatic urothelial carcinoma (mUC) in a real-world setting. Univariable (A) and ...